ZACCARDELLI DAVID (President and CEO) sold 0.8% of their position (125.33K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $627.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/2/2024ACC: 0001104659-24-124756
DirectorOfficer· President and CEO
Since Jan 2021
-125.33K
Net shares
Net seller
$627.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
125.33K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−23.24K
Price / share
$5.00
Trade value
$116.20K
% of position
0.2%
11/27/2024
15.20M→15.18M
Ordinary Shares
Direct
Shares
−98.89K
Price / share
$5.01
Trade value
$495.03K
% of position
0.7%
11/29/2024
15.18M→15.08M
Ordinary Shares
Direct
Shares
−3.20K
Price / share
$5.00
Trade value
$16K
% of position
0.0%
12/2/2024
15.08M→15.08M
Total
Net shares
−125.33K
Net value
-$627.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/27/2024 | S · Sale | −23.24K | $5.00 | $116.20K | 0.2% | 15.20M | 15.18M |
| Ordinary Shares Direct | 11/29/2024 | S · Sale | −98.89K | $5.01 | $495.03K | 0.7% | 15.18M | 15.08M |
| Ordinary Shares Direct | 12/2/2024 | S · Sale | −3.20K | $5.00 | $16K | 0.0% | 15.08M | 15.08M |
| Total | −125.33K | -$627.23K | ||||||
Derivative Transactions0
No derivative transactions reported